Science & HealthUnverifiedGathered automatically from the outlets below; our newsroom hasn't checked it yet. FDA to review uniQure's Huntington's gene therapy, decision due on May 2027 1 hr ago8:15 AM RReuters Read the original at reuters.com ↗